SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001225208-19-000807
Filing Date
2019-01-10
Accepted
2019-01-10 16:50:48
Documents
2
Period of Report
2019-01-01

Document Format Files

Seq Description Document Type Size
1 doc3.html 3  
1 doc3.xml 3 10707
2 nallypoa.txt EX-24 2852
  Complete submission text file 0001225208-19-000807.txt   15031
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Issuer) CIK: 0000310158 (see all company filings)

IRS No.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address
Nally Michael (Reporting) CIK: 0001763945 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-06571 | Film No.: 19520694